WallStreetZenWallStreetZen

NASDAQ: PEAR
Pear Therapeutics Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for PEAR

Based on 5 analysts offering 12 month price targets for Pear Therapeutics Inc.
Min Forecast
$5.00+156.41%
Avg Forecast
$6.00+207.69%
Max Forecast
$8.00+310.26%

Should I buy or sell PEAR stock?

Based on 6 analysts offering ratings for Pear Therapeutics Inc.
Strong Buy
Strong Buy
3 analysts 50%
Buy
2 analysts 33.33%
Hold
1 analysts 16.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PEAR stock forecasts and price targets.

PEAR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Citigroup
Top 7%
94
Strong BuyMaintains$5.00+156.41%2022-11-16
Chardan Capital
Top 2%
99
Strong BuyMaintains$8.00+310.26%2022-11-15
Credit Suisse
Bottom 8%
8
BuyMaintains$7.00+258.97%2022-11-15
BTIG
Top 5%
96
Strong BuyMaintains$5.00+156.41%2022-08-12
Bank of America
Bottom 18%
18
HoldInitiates Coverage On$5.00+156.41%2022-01-26
Cowen & Co.
Bottom 6%
6
BuyInitiates Coverage OnN/AN/A2021-12-16

1 of 1

Forecast return on equity

Is PEAR forecast to generate an efficient return?
Company
50.75%
Industry
11.74%
Market
62.68%
PEAR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PEAR forecast to generate an efficient return on assets?
Company
22.14%
Industry
9.12%
PEAR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PEAR earnings per share forecast

What is PEAR's earnings per share in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$0.82-112.83%
Avg 2 year Forecast
-$0.59-109.23%
Avg 3 year Forecast
-$0.16-102.5%

PEAR revenue forecast

What is PEAR's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$14.7M+28.4%
Avg 2 year Forecast
$64.7M+465.11%
Avg 3 year Forecast
$221.2M+1,832.05%
PEAR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PEAR revenue growth forecast

How is PEAR forecast to perform vs Health Information Services companies and vs the US market?
Company
157.1%
Industry
14.88%
Market
6.67%
PEAR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PEAR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PEAR vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
PEAR$1.95$6.00+207.69%Strong Buy
CMAX$3.06$7.50+145.10%Hold
OPRX$18.70$40.71+117.72%Strong Buy
BBLN$0.50$4.00+708.08%Buy
CPSI$28.27$39.00+37.96%Hold

Pear Therapeutics Stock Forecast FAQ

Is Pear Therapeutics Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: PEAR) stock is to Strong Buy PEAR stock.

Out of 6 analysts, 3 (50%) are recommending PEAR as a Strong Buy, 2 (33.33%) are recommending PEAR as a Buy, 1 (16.67%) are recommending PEAR as a Hold, 0 (0%) are recommending PEAR as a Sell, and 0 (0%) are recommending PEAR as a Strong Sell.

If you're new to stock investing, here's how to buy Pear Therapeutics stock.

What is PEAR's earnings growth forecast for 2022-2024?

(NASDAQ: PEAR) Pear Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 11.14%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.05%.

Pear Therapeutics's earnings in 2022 is -$30,370,000.On average, 1 Wall Street analyst forecast PEAR's earnings for 2022 to be -$114,425,345, with the lowest PEAR earnings forecast at -$114,425,345, and the highest PEAR earnings forecast at -$114,425,345. On average, 4 Wall Street analysts forecast PEAR's earnings for 2023 to be -$82,330,431, with the lowest PEAR earnings forecast at -$94,889,311, and the highest PEAR earnings forecast at -$60,003,535.

In 2024, PEAR is forecast to generate -$22,326,897 in earnings, with the lowest earnings forecast at -$22,326,897 and the highest earnings forecast at -$22,326,897.

What is PEAR's revenue growth forecast for 2022-2024?

(NASDAQ: PEAR) Pear Therapeutics's forecast annual revenue growth rate of 157.1% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 14.88%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 6.67%.

Pear Therapeutics's revenue in 2022 is $11,449,000.On average, 1 Wall Street analysts forecast PEAR's revenue for 2022 to be $2,051,283,629, with the lowest PEAR revenue forecast at $2,051,283,629, and the highest PEAR revenue forecast at $2,051,283,629. On average, 2 Wall Street analysts forecast PEAR's revenue for 2023 to be $9,028,438,829, with the lowest PEAR revenue forecast at $6,293,393,990, and the highest PEAR revenue forecast at $11,763,483,667.

In 2024, PEAR is forecast to generate $30,866,934,605 in revenue, with the lowest revenue forecast at $30,866,934,605 and the highest revenue forecast at $30,866,934,605.

What is PEAR's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: PEAR) forecast ROA is 22.14%, which is higher than the forecast US Health Information Services industry average of 9.12%.

What is PEAR's Price Target?

According to 5 Wall Street analysts that have issued a 1 year PEAR price target, the average PEAR price target is $6.00, with the highest PEAR stock price forecast at $8.00 and the lowest PEAR stock price forecast at $5.00.

On average, Wall Street analysts predict that Pear Therapeutics's share price could reach $6.00 by Nov 16, 2023. The average Pear Therapeutics stock price prediction forecasts a potential upside of 207.69% from the current PEAR share price of $1.95.

What is PEAR's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: PEAR) Pear Therapeutics's current Earnings Per Share (EPS) is $6.39. On average, analysts forecast that PEAR's EPS will be -$0.82 for 2022, with the lowest EPS forecast at -$0.82, and the highest EPS forecast at -$0.82. On average, analysts forecast that PEAR's EPS will be -$0.59 for 2023, with the lowest EPS forecast at -$0.68, and the highest EPS forecast at -$0.43. In 2024, PEAR's EPS is forecast to hit -$0.16 (min: -$0.16, max: -$0.16).

What is PEAR's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: PEAR) forecast ROE is 50.75%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.